Press Releases

12345678910
Digimarc to Attend the 28th Annual Needham Growth Conference on Tuesday, January 13
Digimarc Corporation (Nasdaq: DMRC), a pioneer and global leader in digital identity and authentication solutions, will attend the 28th Annual Needham Growth Conference in New York on Tuesday, January 13, 2026. Digimarc President and CEO Riley McCormack and CFO Charles Beck will host meetings at the event, which is being held at the Lotte New York Palace Hotel.
By Digimarc Corporation · Via Business Wire · December 31, 2025
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 14, 2026.
By ICU Medical, Inc. · Via GlobeNewswire · December 31, 2025
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the filing of a Phase 1/2 Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) seeking regulatory clearance to initiate clinical trials of CYPS317, an investigational allogeneic fibroblast spheroid-based therapy for the treatment of moderate to severe psoriasis.
By FibroBiologics, Inc. · Via GlobeNewswire · December 31, 2025
Trump Media Announces Plans to Distribute Digital Tokens to DJT Shareholders
SARASOTA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, today announced plans to distribute a new digital token to its shareholders in partnership with Crypto.com. The distribution is expected to leverage Crypto.com’s cutting-edge technology, including the high performance, interoperable Cronos blockchain designed for speed, scalability, and seamless connectivity between networks.
By Trump Media & Technology Group · Via GlobeNewswire · December 31, 2025
HMG Strategy Unveils 2026 C-Level Technology Leadership Summit Series: Empowering C-Suite Leaders to Drive Growth, AI Innovation, and Cybersecurity Excellence
FAIRFIELD, Conn., Dec. 31, 2025 (GLOBE NEWSWIRE) -- HMG Strategy, the world’s leading digital platform for CIO and CISO leadership, is proud to announce its highly anticipated 2026 Global C-Level Technology Leadership Summit schedule. C-suite technology executives seeking fresh insight into how technology drives growth, reinvents the enterprise, and elevates leadership impact are invited to explore the upcoming season of premier technology events.
By HMG Strategy · Via GlobeNewswire · December 31, 2025
David Whitcombe, Chief Strategist at LINK FOREX From Market Experience to Long-Term Responsibility, Giving Back to a Wider Community with Professional...
London, United Kingdom - In financial markets, success is often measured by returns, models, and judgment; but according to David
Via First Publisher · December 31, 2025
Vietnam Alternative Lending Report 2025: Market to Grow by 14.2% to Reach $9.91 - Forecasts to 2029 - ResearchAndMarkets.com
The "Vietnam Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
ZenaTech (NASDAQ: ZENA): Turning Drones into High-Growth, Recurring Services for Industrial Infrastructure
The global Drone-as-a-Service (DaaS) market is booming, valued at $9.42 billion in 2022 and projected to grow at a 36.6% CAGR through 2034. Businesses in solar energy, agriculture, telecom, construction, and defense are adopting drones for surveying, inspection, monitoring, and maintenance, recognizing drones deliver data faster, safer, and more cost-effectively than traditional methods. In solar alone, drone-enabled surveying and mapping is projected to reach $1.14 billion by 2027.
Via AB Newswire · December 31, 2025
Thailand Construction Equipment Market Research Report 2025-2030, Profiles of Prominent Vendors - Caterpillar, Komatsu, Volvo CE, Hitachi, and SANY - ResearchAndMarkets.com
The "Thailand Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
U.S. Continuing Medical Education (CME) Market Research Report 2025-2030: Rapid Development in the Medical Industry Landscape and Rising Attention Towards Bit-sized and Specialty CME Programs - ResearchAndMarkets.com
The "U.S. Continuing Medical Education (CME) Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
Home Healthcare Market Research Report 2025-2030 with Exclusive Data on 45 Vendors - ResearchAndMarkets.com
The "Home Healthcare Market Research Report 2025-2030" has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
Aster Guardians Global Nursing Award 2026 Worth $250,000 Extends Deadline Till 11th January 2026
The Aster Guardians Global Nursing Award 2026, an initiative from Aster DM Healthcare – a leading integrated healthcare provider, has announced the extension of its deadline to January 11, 2026. The awards have already received over 134,000 registrations from 214 countries, highlighting its growing global reach and recognition among nurses worldwide. Nurses from around the world can submit their nominations through the dedicated platform at www.asterguardians.com.
By Aster DM Healthcare · Via Business Wire · December 31, 2025
Motus Closes Out 2025 with Breakthrough Innovation, Strategic Expansion, and Industry Recognition
Motus, the leader in vehicle reimbursement, risk mitigation and productivity solutions for companies whose employees drive their own vehicles for work, is closing out 2025 with momentum across product innovation, strategic expansion and industry recognition. Over the past year, Motus strengthened its leadership in the business of driving, helping organizations better manage the costs, risk, and operational realities of employees who drive for work. The company also ends the year with $2.1 billion in approved reimbursements.
By Motus · Via Business Wire · December 31, 2025
Layton Therapist Expands Access to Trauma-Informed Care for Individuals Seeking Emotional Healing and Nervous System Regulation
Spirals & Heartspace offers trauma therapy, somatic therapy, and grief counseling to support healing and resilience in Layton, Utah.
Via Press Release Distribution Service · December 31, 2025
Local Repairs Now Announces National Launch of 24/7 Home Services Connection Platform
Local Repairs Now launches nationwide, providing homeowners with around-the-clock access to trusted home services professionals across the United States through a streamlined online platform.
Via Press Release Distribution Service · December 31, 2025
2025 Corporate Review
VANCOUVER, BC, December 31 st . 2025 / - TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of operating initiatives over the past year following the integration of the DPX™ platform into the BioVaxys business.
Via TheNewswire.com · December 31, 2025
Doubleview Gold Corp. Closes Second Tranche of $104,000 Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) (the "Company"...
Via Newsfile · December 31, 2025
Western Asset Inflation-Linked Opportunities & Income Fund (WIW or “the Fund”; CUSIP: 95766R104) Announces Notification of Sources of Distributions
Western Asset Inflation-Linked Opportunities & Income Fund [NYSE: WIW]
LMP Capital and Income Fund Inc. (SCD or “the Fund”; CUSIP: 50208A102) Announces Notification of Sources of Distributions
LMP Capital and Income Fund Inc. [NYSE: SCD]
Franklin Templeton Announces 19(a) Notices for Closed-End Municipal Funds
The 19(a) monthly distribution notices for Putnam Managed Municipal Income Trust (NYSE: PMM) and Putnam Municipal Opportunities Trust (NYSE: PMO) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement.
By Franklin Templeton · Via Business Wire · December 31, 2025
Franklin Templeton Announces 19(a) Notices for Closed-End Taxable Funds
The 19(a) monthly distribution notices for Putnam Master Intermediate Income Trust (NYSE: PIM) and Putnam Premier Income Trust (NYSE: PPT) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement.
By Franklin Templeton · Via Business Wire · December 31, 2025
Western Asset Inflation-Linked Income Fund (WIA or “the Fund”; CUSIP: 95766Q106) Announces Notification of Sources of Distributions
Western Asset Inflation-Linked Income Fund [NYSE: WIA]
Western Asset Emerging Markets Debt Fund Inc. (EMD or “the Fund”; CUSIP: 95766A101) Announces Notification of Sources of Distributions
Western Asset Emerging Markets Debt Fund Inc. [NYSE: EMD]
YouCam Apps Rings in 2026: AI-Powered "New Year, New You" Features to Upgrade Your Holiday Social Feed
Perfect Corp. (NYSE: PERF), the leading artificial intelligence (AI) and augmented reality (AR) beauty and fashion tech solutions provider, announced the launch of an interactive suite of 2026 New Year content across the YouCam app series, including YouCam Makeup, YouCam Perfect, YouCam AI Pro, YouCam Enhance and YouCam Video. With over 1.1 billion total downloads, the YouCam apps are transforming how users celebrate the holidays, offering new ways to visualize their New Year’s resolutions and create viral-ready social content using the latest Generative AI.
By Perfect Corp. · Via Business Wire · December 31, 2025
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the U.S. Food and Drug Administration (FDA or the Agency) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism.
By Corcept Therapeutics Incorporated · Via Business Wire · December 31, 2025
BrandywineGLOBAL - Global Income Opportunities Fund Inc. (BWG or “the Fund”; CUSIP: 10537L104) Announces Notification of Sources of Distributions
BrandywineGLOBAL - Global Income Opportunities Fund Inc. [NYSE: BWG]
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of results from subgroup analyses of the phase 3 FOCUS study. The publication, titled “Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma” was published in the Journal of Cancer Research and Clinical Oncology. The analysis assessed efficacy and safety in subgroups of patients treated with Delcath’s HEPZATO KIT, a drug/device combination for liver-directed treatment of mUM patients. The HEPZATO KIT is currently the only liver-directed treatment to be approved by the FDA for patients with unresectable mUM. The article provides clinically relevant subgroup analyses of key efficacy endpoints, including overall response rate (ORR), progression-free survival (PFS) and overall survival (OS), and safety categories. Prespecified subgroups included age (<65 or ≥65 years), sex (male or female) geographic region (ex-US or US) extent of tumor liver involvement (1-25% or 26-50%), hepatic tumor burden (above or below median), presence of extrahepatic lesions (yes or no), baseline LDH (low/normal or elevated) and number of prior therapies (0 or 1+).
By Delcath Systems, Inc. · Via Business Wire · December 31, 2025
Thiel Capital Opens Miami Office
Thiel Capital, the private investment firm founded by technology investor and entrepreneur Peter Thiel, has opened an office in Miami, Florida.
By Thiel Capital · Via Business Wire · December 31, 2025
CMCT Declares Preferred Stock Dividends
Creative Media & Community Trust Corporation (NASDAQ: CMCT) (the “Company”) announced today that its Board of Directors has declared preferred stock dividends on its Series A, Series A1 and Series D Preferred Stock for the fourth quarter of 2025. The dividend will be payable on January 15, 2026 to holders of record on January 5, 2026.
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 44th Annual J.P Morgan Healthcare Conference on January 14, 2026 at 9:45 a.m. PT.
By Establishment Labs Holdings Inc. · Via Business Wire · December 31, 2025
America250 Launches America Gives to Make 2026 the Biggest Year of Service in American History
America250, the official nonpartisan organization established by Congress to lead the nation’s 250th anniversary commemoration, today launched its latest tentpole program, America Gives, a nationwide initiative designed to make 2026 the largest year of volunteerism in U.S. history.
By America250 · Via Business Wire · December 31, 2025
Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders
VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”), a digital health platform enabling on-demand care, pharmacy fulfillment, and enterprise healthcare services across the United States, today announced its entry into the rapidly expanding at-home sexually transmitted infection (“STI”) pre-screening market through an exclusive distribution agreement with Health Screen Collective (“HSC”).
By Hydreight Technologies Inc. · Via GlobeNewswire · December 31, 2025
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
TARPON SPRINGS, Fla., December 31, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor—today issued the following letter to shareholders from the Company’s Chief Executive Officer.Dear Shareholders,
By Allarity Therapeutics, Inc. · Via GlobeNewswire · December 31, 2025
Spondyloarthritis (Spondyloarthropathy) Global Clinical Trials Review 2025: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - ResearchAndMarkets.com
The "Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
Westin Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Rights
New York, NY, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Westin Acquisition Corp (NASDAQ): WSTNU, the “Company”), a Cayman Islands exempted company, announced that holders of its 5,750,000 units sold in the Company’s initial public offering may elect to separately trade the ordinary shares and rights included in the units, commencing on or about December 31, 2025.
By Westin Acquisition Corp · Via GlobeNewswire · December 31, 2025
NANO Nuclear Energy Extends Relationship with the University of Illinois Urbana-Champaign to Construct and Operate the First KRONOS MMR Energy System on U.S. University Land
New York, New York--(Newsfile Corp. - December 31, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the...
Via Newsfile · December 31, 2025
Lupus Nephritis Global Clinical Trials Market Report 2025: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - ResearchAndMarkets.com
The "Lupus Nephritis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
The Quantum Shield: Hardening AI & Critical Infrastructure
Issued on behalf of QSE - Quantum Secure Encryption Corp.
By USA News Group · Via GlobeNewswire · December 31, 2025
ICG FUNDING Introduces AI-Powered Underwriting to Enable 24/7 Small Business Loan Decisions
BROOKLYN, NY / ACCESS Newswire / December 31, 2025 / ICG FUNDING has announced the deployment of an AI-driven underwriting engine designed to provide qualified small businesses with funding decisions within 24 hours, regardless of time or day. The development reflects a broader shift within the fintech sector toward faster, data-driven access to working capital for small and medium-sized enterprises who apply for business loans.
Via ACCESS Newswire · December 31, 2025
Jeffs’ Brands: Fort Technology Inc. Announces Intention to List its Common Shares on the Nasdaq Capital Market
Tel Aviv, Israel, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company strategically pivoting into homeland security, today announced that the board of directors of its majority-owned subsidiary, Fort Technology Inc. (TSXV: FORT) (“Fort”), approved a strategic initiative to pursue an uplisting of Fort’s common shares on the Nasdaq Capital Market (“Nasdaq”).
By Jeffs' Brands Ltd · Via GlobeNewswire · December 31, 2025
IgA Nephropathy (Berger's Disease) Global Clinical Trials Market Review 2025 - ResearchAndMarkets.com
The "IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025
Fort Technology Inc. Announces Intention To Pursue Listing Of Its Common Shares On Nasdaq Capital Market
December 31, 2025 – Vancouver, British Columbia – TheNewswire - Fort Technology Inc. (TSXV: FORT) (“Fort Technology” or the “Company”) is pleased to announce that its board of directors has approved a strategic initiative to pursue an uplisting of the Company’s common shares to the Nasdaq Capital Market (“Nasdaq”).
Via TheNewswire.com · December 31, 2025
Capstone Extends Revolving Credit Facility with Berkshire Bank, Strengthening Liquidity and Financial Flexibility
Extension preserves liquidity runway, carries no added cost, and provides flexibility as Capstone advances its disciplined growth strategy.
Via ACCESS Newswire · December 31, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new executive and non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
By Abeona Therapeutics Inc. · Via GlobeNewswire · December 31, 2025
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
MedSell commercializes Lumee™ Oxygen tissue monitoring in France, building upon distributor partnerships in Spain, Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia, to now reach approximately 200,000 annual CLI cases in the European Union
By Profusa, Inc. · Via GlobeNewswire · December 31, 2025
The Builder’s Market: 5 Gold Stocks Transitioning to Cash Flow
Issued on behalf of Lake Victoria Gold Ltd.
By Equity Insider · Via GlobeNewswire · December 31, 2025
Metavesco CEO Buys 142,857,142 Common Shares and Provides Shareholder Update
CUMMING, GA - December 31, 2025 ( NEWMEDIAWIRE ) - Metavesco, Inc. (OTC: MVCO ), a diversified holding company and the architect of the growing OTCfi ecosystem, today announced that Chief Executive Officer Ryan Schadel has purchased 142,857,142 shares of the Company’s common stock, underscoring management’s confidence as Metavesco enters a critical execution phase.
Via TheNewswire.com · December 31, 2025
Metavesco CEO Buys 142,857,142 Common Shares and Provides Shareholder Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · December 31, 2025
PCBsync PCB Assembly Introduces Full-Scale Electronic Manufacturing Service
SHENZHEN, CN / ACCESS Newswire / December 31, 2025 / PCBsync, a trusted name in PCB assembly and electronic manufacturing service, today announced the launch of its comprehensive full-scale electronic manufacturing service platform. This strategic expansion positions PCBsync as a complete turnkey solution provider for businesses seeking reliable PCB assembly services combined with advanced electronic manufacturing service capabilities.
Via ACCESS Newswire · December 31, 2025
Luxury Hotel Analysis Report 2025: Market Snapshot, Key Trends, Deals, Key Insights, Outlook, and Company Profiles - ResearchAndMarkets.com
The "Luxury Hotel Market (2025)" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 31, 2025